Physician profile
Christopher Kirkpatrick
NPI 1275890774
$1,244.41
in general payments reported to CMS, 2019-2025
12 companies · $489 in 2025
The $489 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $111 · 2020: $12.92 · 2021: $172 · 2022: $129 · 2023: $109 · 2024: $221 · 2025: $489.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $787 · Honoraria: $32.44.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $786.73 |
| Honoraria | $32.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rxsight INC | $286.47 | 2021-2025 | Rxsight Contact Lens, Rxsight Injector Cartridge, Rxsight Injector Handpiece |
| Glaukos Corporation | $225.71 | 2019-2025 | Idosetr |
| Alcon Vision LLC | $164.92 | 2021-2025 | Clareon |
| New World Medical,INC. | $144.85 | 2021-2025 | Clearpath, Kahook Dual Blade, Via360 |
| Abbvie INC. | $135.86 | 2023-2025 | |
| Johnson & Johnson Surgical Vision, INC. | $119.09 | 2019-2025 | Tecnis Simplicity |
| Novartis Pharmaceuticals Corporation | $74.32 | 2022-2023 | |
| Allergan, INC. | $28.08 | 2019-2020 | |
| Sun Pharmaceutical Industries INC. | $17.61 | 2019 | |
| Mallinckrodt Hospital Products INC. | $16.43 | 2022 | |
| Biotissue Holdings INC. | $15.97 | 2023 | |
| Eyevance Pharmaceuticals LLC | $15.10 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Kirkpatrick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.